India will get 50% of Oxford Coronavirus vaccine doses produced; Serum Institute of India will start Phase 3 trials of vaccine in August: Adar Poonawalla | The Times of India
The promising COVID-19 vaccine was developed by the scientists of the Jenner Institute (Oxford University) and British-Swedish pharma firm, AstraZeneca has been given the license to mass-produce the potential vaccine.…